Trial NCT05054621
Publication Chen C, Nat Commun, 2022
Primary outcome on the report: Immune response by neutralizing antibody titer at day 28 after the booster vaccination.

Note: The risk of bias by domain corresponds to the highest risk of bias among outcomes by domain.
The overall risk of bias corresponds to the overall highest risk of bias assessed among outcomes.